RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how well patients will respond to treatment. PURPOSE: The purpose of this study is to collect and store blood and bone marrow samples from patients with hematologic cancer to be tested in the laboratory.
Primary objective: * Maintain and expand tissue repositories of highly characterized samples from patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, chronic myelogenous leukemia, or myelodysplastic syndromes. Other objectives as funding permits: * Develop laboratory assays for rapid and precise diagnosis of leukemia using bone marrow and peripheral blood samples. * Determine biologic, genetic, and molecular parameters that distinguish different subtypes of human leukemia with differing responses to therapy, and develop "risk-adapted" therapeutic approaches based on these parameters to tailor therapeutic regimens, randomize or stratify patients in clinical trials, or otherwise assist in therapeutic decision-making. * Develop new automated and standardized laboratory methods for the detection and monitoring of therapeutic responsiveness and minimal residual disease in patients and use this information to design clinical trials. OUTLINE: Patients receive treatment as directed by the Southwest Oncology Group (SWOG) study to which they are registered. Patients undergo collection of peripheral blood (myeloid leukemia) or venous blood (lymphoid leukemia) and bone marrow at baseline, at the time of response or remission, and at the time of progression or relapse. Additional collections may take place according to the guidelines of the study in which the patient is registered. Specimens are stored for use in laboratory research. PROJECTED ACCRUAL: Samples from a maximum of 1,000 patients will be collected for this study.
Study Type
OBSERVATIONAL
Enrollment
1,294
Maintenance and expansion of tissue repositories of highly characterized samples from patients with ALL, CLL, AML, CML, or myelodysplastic syndromes
Time frame: While protocol was open
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Burbank, California, United States
Peninsula Medical Center
Burlingame, California, United States
North Bay Cancer Center
Fairfield, California, United States
Sutter Health - Western Division Cancer Research Group
Novato, California, United States
University of California Davis Cancer Center
Sacramento, California, United States
California Pacific Medical Center - California Campus
San Francisco, California, United States
Stanford Cancer Center
Stanford, California, United States
Sutter Solano Medical Center
Vallejo, California, United States
...and 282 more locations